Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-30

FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride as a generic, confirming approval under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sertraline hydrochloride (sertraline hydrochloride)

Snippet

SUPPL AP for SERTRALINE HYDROCHLORIDE (SERTRALINE HYDROCHLORIDE)